## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `ara-290-post-surgical-nerve`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `ara-290-post-surgical-nerve` v27 · content_hash `394303075d74bdb1…` · thread_head genesis · 25 DIVs
- **thesis (c3):** No human trials have tested ARA-290 in post-surgical nerve damage.
  - c5 [human/active] ARA-290 activates IRR to promote anti-inflammatory and repair pathways rather than symptomatic pain masking.
  - c6 [human/active] Commercial vendors and clinics market this compound (9 commercial/clinic sources catalogued) — marketing material, not evidence.
  - c8 [human/active] Ongoing or completed trial on ARA 290 for sarcoid-associated small fiber neuropathy and nerve fiber regeneration.
  - c12 [human/active] 2024 review detailing EPO, ARA290, and CHBP mechanisms and protective effects in peripheral nerve injury models, noting ARA290's neuroprotective role despite sh
  - c31 [human/active] Blog post on ARA-290 for peripheral nerve damage including injury-related, referencing sarcoidosis studies.
  - c37 [human/active] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - c41 [human/active] There is a lack of data on the comparative efficacy of ARA-290 against standard treatments for post-surgical nerve damage.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `ara-290-post-surgical-nerve`
- **title:** ARA-290 for Post-Surgical Nerve Damage: Evidence Review
- **url:** https://miscsubjects.com/a/ara-290-post-surgical-nerve
- **register:** source_ledger
- **updated:** 2026-07-17T02:38:15.458Z
- **tags:** peptide, topic

## Body

## Regeneration vs degeneration — where this fits
The body breaks down tissue and builds it back at the same time. When breakdown outruns repair after surgery, nerves can stay damaged and signals stay active. ARA-290 is studied for the repair side of this balance in nerve tissue.

## What it is
ARA-290 is a short chain of amino acids. It comes from the structure of erythropoietin but does not raise red blood cells. Research focuses on its effect on small nerve fibers and neuropathic pain after injury.

## How it works
It binds a receptor called the innate repair receptor. Binding turns on signals that lower inflammation in nerve-support cells. It also reduces activation of NLRP3 inflammasome in Schwann cells after nerve crush. These steps are shown in rat models.

## Why it would work (logic chain)
If nerve injury causes ongoing inflammation, then lowering that inflammation could allow regrowth signals to dominate. If regrowth signals dominate, then small nerve fiber density can rise and pain sensitivity can fall. Rat studies test this chain after surgical-type nerve cuts. Human sarcoidosis trials test the same chain in small fiber loss.

## Why people take it
People with ongoing nerve pain after surgery or with small fiber neuropathy look for options that target repair rather than only masking pain. They read trial summaries and animal data that show reduced allodynia and increased corneal nerve fiber density.

## How many people take it
No public count exists. The ledger records ten Reddit posts, one X post, and one Instagram source. Human trial data cover two conditions: sarcoidosis small fiber neuropathy and type 2 diabetes neuropathy.

## Evidence inventory
32 total sources.  
18 studies catalogued.  
10 Reddit posts.  
1 X post.  
1 other anecdote source.  
Human claims: 2.  
Preclinical claims: 11.  
Anecdotal claims: 15.  

Human data come from sarcoidosis and diabetes trials. Preclinical data come from spared nerve injury, sciatic crush, and diabetic mouse models. Anecdote sources are self-reports on forums and social media.

## What scientists say
Source s2: 28 days of daily use in sarcoidosis patients improved neuropathic symptoms and raised corneal small nerve fiber density.  
Source s3: In type 2 diabetes, neuropathic symptoms on the PainDetect scale improved and a subgroup showed higher corneal nerve fiber density.  
Source s7: In rats with spared nerve injury, ARA-290 given on days 1, 3, 6, 8, and 10 produced dose-dependent, long-term relief of mechanical and cold pain. The effect lasted weeks after the last dose.  
Source s22: In rats after sciatic nerve crush, ARA-290 reduced NLRP3 inflammasome activity in Schwann cells and supported functional recovery.  
Source s6: The same spared nerve injury model showed ARA-290 prevented neuropathic pain development when started early.  
These studies prove short-term symptom change and some fiber density increase in the tested groups. They do not prove the same results occur after every type of surgery or in every patient.

## What people say on Reddit
Source s10: User followed the 28-day sarcoidosis protocol and reported definite benefit after 12 days with slight improvement in numbness.  
Source s14: User at day 8 reported walking over 14,000 steps pain free after titrating to the trial amount.  
Source s15: User said feeling started to come back in areas that had been numb.  
Source s16: Post-surgical back patient with peripheral neuropathy started ARA-290 and reported no side effects after two injections.  
Source s17: User after one month called it the most helpful option tried and noted significant improvement in severe neuropathy.  
Source s18: User developed painful tingling at 2 mg and stopped; pain eased after stopping.  
Source s19: User said pain relief was temporary and required repeated courses.  
Source s20: User with disc-related nerve pain reported no benefit or side effects after less than one week.  
These posts are real user reports. They are not controlled trials.

## What people say on X
Source s21: One user stated ARA-290 is amazing for nerve pain in neck and shoulders.

## What we do not know
No completed human trial tests ARA-290 specifically for post-surgical nerve damage. Long-term safety data beyond 28 days are absent. It is unknown whether increased corneal nerve fiber density in sarcoidosis patients predicts repair in surgical nerve injury. The 2025 rat study on NLRP3 shows one mechanism but does not confirm the same pathway works in humans after surgery. How long any reported benefit lasts after stopping is not measured in controlled settings.

## Safety and limits
Source s18 reports one case of increased painful tingling that resolved after stopping. Other Reddit users report no side effects. Human trials up to 28 days did not list major adverse events in the summaries. No long-term human safety data exist for repeated or extended use. The ledger contains no dose information.

## Claims (48)

- **c59** [mechanistic w=0.3] Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
  - who_claims: miscsubjects protocol
  - slot: limitations
- **c31** [human w=0.8] Blog post on ARA-290 for peripheral nerve damage including injury-related, referencing sarcoidosis studies.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s31
- **c7** [preclinical w=0.5] Details dose-dependent long-term relief of neuropathic pain in spared nerve injury rat model.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s7
- **c_map_ara-290-post-surgical-ne** [system w=0.35] Combinatorial mapping (transparent): ara-290 vs post-surgical-nerve — regen=0.888, degen=0.83, Δ=0.057. Method: layer_relevance(0.95) × evidence_factor(0.85); catalog.degen_score for Post-surgical nerve injury.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
- **c58** [system w=0.35] ARA-290 for Post-Surgical Nerve Damage: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
  - who_claims: miscsubjects protocol
  - slot: what_it_is
- **c1** [human w=0.8] Human trials in sarcoidosis SFN showed symptom improvement and increased corneal nerve fiber density after 28 days of ARA-290.
  - who_claims: grok/4.3-populate
  - slot: mechanism
  - sources: s1, s2
- **c2** [human w=0.8] Human trial in type 2 diabetes neuropathy showed improved neuropathic symptoms and CNFD increase in subgroup.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
  - sources: s3
- **c5** [human w=0.8] ARA-290 activates IRR to promote anti-inflammatory and repair pathways rather than symptomatic pain masking.
  - who_claims: grok/4.3-populate
  - slot: mechanism
  - sources: s1
- **c6** [human w=0.8] Commercial vendors and clinics market this compound (9 commercial/clinic sources catalogued) — marketing material, not evidence.
  - who_claims: commercial vendors
  - slot: what_is_known
  - sources: s6, s24, s26, s27, s28, s29, s30, s1, s8
- **c8** [human w=0.8] Ongoing or completed trial on ARA 290 for sarcoid-associated small fiber neuropathy and nerve fiber regeneration.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s8
- **c12** [human w=0.8] 2024 review detailing EPO, ARA290, and CHBP mechanisms and protective effects in peripheral nerve injury models, noting ARA290's neuroprotective role despite short half-life limitations.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s12
- **c37** [human w=0.8] Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
  - who_claims: system/protocol
  - slot: disclaimer
- **c41** [human w=0.8] There is a lack of data on the comparative efficacy of ARA-290 against standard treatments for post-surgical nerve damage.
  - who_claims: kimi-collaborator
  - slot: what_is_unknown
  - sources: s1
- **c9** [preclinical w=0.5] Shows ARA290 benefits in diabetic neuropathy model, relevant to nerve damage repair.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s9
- **c22** [preclinical w=0.5] 2025 study showing ARA290 (and EPO) inhibits NLRP3 inflammasome in Schwann cells post-sciatic nerve crush injury in rats, promoting repair and functional recovery.
  - who_claims: grok/grok-4.3
  - slot: mechanism
  - sources: s22
- **c4** [mechanistic w=0.3] Rat models of sciatic nerve injury show reduced allodynia and nerve repair effects with ARA-290.
  - who_claims: grok/4.3-populate
  - slot: what_is_known
  - sources: s5
- **c40** [mechanistic w=0.4] While the study mentioned in claim c1 shows increased corneal nerve fiber density, it does not necessarily imply direct nerve repair in the context of post-surgical nerve damage, as the study was conducted in sarcoidosis patients, which may have different underlying mechanisms.
  - who_claims: kimi/moonshot-v1-8k (adversary)
- **c43** [mechanistic w=0.4] While the human trial mentioned in claim c2 showed improved neuropathic symptoms and CNFD increase in a subgroup, the applicability of these findings to post-surgical nerve damage specifically is uncertain due to differences in patient populations and study context.
  - who_claims: kimi/moonshot-v1-8k (adversary)
- **c10** [anecdotal w=0.3] User anecdote of self-experimenting with ARA-290 for SFN/neuropathy, reporting symptom improvement and nerve healing hints.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s10
- **c11** [anecdotal w=0.3] Reddit discussion thread with user experiences trying ARA-290 for neuropathy symptoms.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s11
- **c14** [anecdotal w=0.3] User anecdote reporting significant pain relief and improved mobility from ARA-290 for chronic neuropathy symptoms after 8 days of use.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s14
- **c15** [anecdotal w=0.3] Anecdotal report of temporary symptom improvement (tingling, temperature awareness) from short-term ARA-290 use for suspected small fiber neuropathy.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s15
- **c16** [anecdotal w=0.3] Post-surgical (back surgery) neuropathy patient reports starting ARA-290 protocol with no side effects so far and optimism based on studies.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s16
- **c17** [anecdotal w=0.3] Positive user report of significant improvement in severe neuropathy after 1 month of ARA-290.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s17
- **c18** [anecdotal w=0.3] Negative experience: painful tingling side effect leading to stopping ARA-290; pain subsided after discontinuation.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s18
- **c19** [anecdotal w=0.3] User reports temporary pain relief from ARA-290 requiring ongoing use.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s19
- **c20** [anecdotal w=0.3] User with post-disc herniation (surgical context implied) nerve pain reports no benefits or side effects after short use of ARA-290; planning longer cycle.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s20
- **c21** [anecdotal w=0.3] Positive anecdotal report of ARA-290 helping nerve pain in neck and shoulders.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s21
- **c32** [anecdotal w=0.3] Instagram reel by foot/ankle surgeon recommending ARA-290 specifically for post-operative nerve pain and nerve injury.
  - who_claims: grok/grok-4.3
  - slot: who_claims_what
  - sources: s32
- **c39** [anecdotal w=0.3] Anecdotal reports of ARA-290's effectiveness come from various individuals on platforms like Reddit.
  - who_claims: kimi-collaborator
  - slot: who_claims_what
  - sources: s10
- **c42** [anecdotal w=0.3] Anecdotal reports from patients on online forums suggest ARA-290 may provide relief for post-surgical nerve pain, but these are not systematically collected or verified.
  - who_claims: kimi-collaborator
  - slot: who_claims_what
  - sources: s10
- **c44** [anecdotal w=0.3] A Reddit user provides their personal assessment regarding the effectiveness of ARA-290.
  - who_claims: gemini-collaborator
  - slot: who_claims_what
  - sources: s10
- **c46** [anecdotal w=0.3] Positive anecdotal report of significant nerve damage area reduction and symptom improvement from ARA-290 use post-vein ablation procedure (saphenous nerve axonal damage).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s33
- **c47** [anecdotal w=0.3] Negative user experience reporting no pain relief or symptom improvement after 14 days of ARA-290 (user continued briefly but later discontinued without benefit).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s34
- **c48** [anecdotal w=0.3] User reports no effect from 4mg/day ARA-290 for 8 weeks on neuropathy (anecdotal, not advice). Another similar negative report for 60 days.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s35
- **c49** [anecdotal w=0.3] User tried ARA290 but stopped due to insufficient relief and cost (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s36
- **c50** [anecdotal w=0.3] Mixed anecdotal outcome: limited overall effect from 2 months ARA290 but some reduction in nerve overfiring symptoms (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s37
- **c51** [anecdotal w=0.3] Positive anecdotal report of ARA-290 helping post-back surgery nerve issues (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s38
- **c52** [anecdotal w=0.3] Anecdotal dosing and stacking advice for nerve repair (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s39
- **c53** [anecdotal w=0.3] Positive anecdotal report on ARA-290 for nerve repair and inflammation (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s40
- **c54** [anecdotal w=0.3] User reports trying 4mg daily ARA-290 (anecdotal) with uncertain effects on neuropathy alongside other treatments; no clear positive or negative outcome detailed for post-surgical nerve issues.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s41
- **c55** [anecdotal w=0.3] Anecdotal comment on ARA-290 for SFN/EM (related nerve pain): temporary relief in some, loses efficacy, best for central sensitization; suggests short trial from peptide sources (anecdotal, not advice).
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s42
- **c56** [anecdotal w=0.3] Discussion of ARA-290 for neuropathic pain including potential nerve support; general positive research mention but no specific user outcomes or post-surgical anecdotes here.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s43
- **c57** [anecdotal w=0.3] User considering ARA-290 for personal nerve damage (anecdotal intent); no outcome reported.
  - who_claims: grok-4.3
  - slot: who_claims_what
  - sources: s44
- **c3** [speculative w=0.12] No human trials have tested ARA-290 in post-surgical nerve damage.
  - who_claims: grok/4.3-populate
  - slot: what_is_unknown
  - sources: s4
- **c13** [speculative w=0.12] Blog post discussing ARA-290 for peripheral nerve regeneration, including post-surgical nerve damage recovery in combination with BPC-157.
  - who_claims: grok/grok-4.3
  - slot: what_is_known
  - sources: s13
- **c23** [speculative w=0.12] Research article on rat sciatic nerve crush model (relevant to post-injury/surgical nerve damage); ARA290 reduces early inflammation via NLRP3 inhibition in Schwann cells, aiding regeneration.
  - who_claims: grok/grok-4.3
  - slot: mechanism
  - sources: s23
- **c25** [speculative w=0.12] 2016 review discussing ARA290 (targeting innate repair receptor) in post-surgical neuropathic pain models like spared nerve injury (SNI) and sciatic nerve injury, showing long-term relief of allodynia.
  - who_claims: grok/grok-4.3
  - slot: mechanism
  - sources: s25

## Voxel graph (48 atoms · 103 edges)
- full graph: https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (40 of 44)
- chain valid: yes · head: `47a68756fca87824`

### s1 · pubmed · ok
- title: Targeting the innate repair receptor to treat neuropathy
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/
- summary: Review summarizing human sarcoidosis and T2D trials plus preclinical data.
- quote: In patients with sarcoidosis, ARA290 significantly improved neuropathic and autonomic symptoms... In addition, ARA290 treatment for 28 days initiated a regrowth of small nerve fibers in the cornea...
- claim_ids: c1, c5, c41, c6
- hash: `3f27e6e11408236a`

### s2 · pubmed · ok
- title: ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density
- url: https://pubmed.ncbi.nlm.nih.gov/24136731/
- summary: Primary sarcoidosis SFN trial results.
- quote: 28 d of daily subcutaneous administration of ARA 290... significantly improves neuropathic symptoms... significant increase in corneal small nerve fiber density
- claim_ids: c1
- hash: `5fec5a49d472937a`

### s3 · pubmed · ok
- title: ARA 290... Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC4365069/
- summary: T2D neuropathy phase 2 trial.
- quote: Neuropathic symptoms as assessed by the PainDetect questionnaire improved significantly... subjects with a mean CNFD >1 standard deviation from normal showed a significant increase in CNFD
- claim_ids: c2
- hash: `e5babafece44e9b9`

### s4 · other · ok
- title: ARA-290: Neuropathic Pain & Nerve Repair
- url: https://www.truehealwellness.com/peptides-research/ara-290
- summary: Explicit statement of evidence gap.
- quote: For post-surgical nerve pain, the rationale is preclinical (an animal surgical-nerve-injury study); no human trial has tested it.
- claim_ids: c3
- hash: `fe67582a75ebdca7`

### s5 · pubmed · ok
- title: Discovery of a master regulator of injury and healing
- url: https://pubmed.ncbi.nlm.nih.gov/25549226/
- summary: Preclinical nerve injury models referenced.
- quote: ARA 290 has effective and prolonged (up to 20 weeks) anti-allodynic effects... after nerve injury
- claim_ids: c4
- hash: `44da2cc99c0817a5`

### s6 · pubmed · ok
- title: ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response
- url: https://pubmed.ncbi.nlm.nih.gov/21873879/
- summary: Preclinical study on spared nerve injury (post-surgical model) showing ARA290 prevents and relieves neuropathic pain long-term.
- quote: ARA290 is a promising new drug in the prevention of peripheral nerve injury -induced neuropathic pain in humans.
- claim_ids: c6
- hash: `e39739e51f5a0571`

### s7 · pubmed · ok
- title: ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response
- url: https://pubmed.ncbi.nlm.nih.gov/24529189/
- summary: Details dose-dependent long-term relief of neuropathic pain in spared nerve injury rat model.
- quote: Following a spared nerve injury in rats, vehicle or ARA290 (administered in either one of 4 doses: 3, 10, 30 and 60 μg/kg) was administered on days 1, 3, 6, 8 and 10.
- claim_ids: c7
- hash: `91f2d1d2744fb42c`

### s8 · clinical_trial · ok
- title: Study of Efficacy of ARA 290 on Corneal Nerve Fiber Abundance in Patients With Sarcoidosis
- url: https://clinicaltrials.gov/study/NCT02039687
- summary: Ongoing or completed trial on ARA 290 for sarcoid-associated small fiber neuropathy and nerve fiber regeneration.
- quote: The purpose of this study is to determine whether ARA 290 , a new class of compound, is effective in the treatment of the neuropathic symptoms of sarcoidosis ...
- claim_ids: c8, c6
- hash: `f7dfd894e3845101`

### s9 · pubmed · ok
- title: The erythropoietin-derived peptide ARA290 reverses established neuritic dystrophy in Akita (Ins2Akita) diabetic mouse sympathetic ganglia
- url: https://pubmed.ncbi.nlm.nih.gov/23262243/
- summary: Shows ARA290 benefits in diabetic neuropathy model, relevant to nerve damage repair.
- quote: ARA290 may be beneficial in the treatment of neuropathic pain symptoms where signs of nerve injury are absent on clinical assessment.
- claim_ids: c9
- hash: `8ab1f09b374f525d`

### s10 · reddit · ok
- title: Effectiveness of ARA-290...My Assessment
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/v44s3q/effectiveness_of_ara290my_assessment/
- summary: User anecdote of self-experimenting with ARA-290 for SFN/neuropathy, reporting symptom improvement and nerve healing hints.
- quote: I followed the clinical phase II protocol from 2017. 28 days, 4mg/day... Definite benefit, although it took12 days for it to start working... Slight improvement in numbness.
- claim_ids: c10, c39, c42, c44
- hash: `9e752736f03df50f`

### s11 · reddit · ok
- title: Peptide ARA-290
- url: https://www.reddit.com/r/neuropathy/comments/1o33123/peptide_ara290/
- summary: Reddit discussion thread with user experiences trying ARA-290 for neuropathy symptoms.
- quote: Has anyone tried the peptide ARA-290. It has clinical evidence of helping to slow or stop neuropathy and allow nerves to heal.
- claim_ids: c11
- hash: `1393304c499d39d2`

### s12 · review · http_403
- title: The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury
- url: https://www.sciencedirect.com/science/article/abs/pii/S1567576924009731
- summary: 2024 review detailing EPO, ARA290, and CHBP mechanisms and protective effects in peripheral nerve injury models, noting ARA290's neuroprotective role despite short half-life limitations.
- quote: This review summarizes for the first time the role of ARA290 and CHBP, derivatives of EPO in peripheral nerve injury.
- claim_ids: c12
- hash: `9b5e7898a793927b`

### s13 · medical · ok
- title: Healing Nerve Damage: ARA-290 and BPC-157
- url: https://alphacarbonlabs.com/blog/peripheral-nerve-regeneration-the-synergistic-potential-of-ara-290-and-bpc-157-in-neuropathic-research
- summary: Blog post discussing ARA-290 for peripheral nerve regeneration, including post-surgical nerve damage recovery in combination with BPC-157.
- quote: Post-Surgical Recovery. Surgery inevitably cuts through nerves.
- claim_ids: c13
- hash: `c0b11c83d8c3ab61`

### s14 · reddit · ok
- title: ARA290 peptide AND Rebuilder 2407 have changed my life!
- url: https://www.reddit.com/r/neuropathy/comments/1tncdyo/ara290_peptide_and_rebuilder_2407_have_changed_my/
- summary: User anecdote reporting significant pain relief and improved mobility from ARA-290 for chronic neuropathy symptoms after 8 days of use.
- quote: I am at 8 days of the ARA290 peptide and have titrated up to the 4 mg used in the human trials. ... Yesterday was by FAR the best day of the past 15 months! I walked over 14,000 steps pain free!
- claim_ids: c14
- hash: `256080897ea7eb1a`

### s15 · reddit · ok
- title: Do I have SFN? ARA-290 helped
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/1ce0ub5/do_i_have_sfn_ara290_helped/
- summary: Anecdotal report of temporary symptom improvement (tingling, temperature awareness) from short-term ARA-290 use for suspected small fiber neuropathy.
- quote: I tried the peptide ARA-290 because it was supposed to help with nerve re-growth. It was amazing! Feeling started to come back...
- claim_ids: c15
- hash: `960167d9ccd16b39`

### s16 · reddit · ok
- title: ARA-290 peptide — any experience reports?
- url: https://www.reddit.com/r/neuropathy/comments/hreepv/ara290_peptide_any_experience_reports/
- summary: Post-surgical (back surgery) neuropathy patient reports starting ARA-290 protocol with no side effects so far and optimism based on studies.
- quote: I am 55 years old ... I had L5/S1 anterior back surgery about 4 yrs ago. Unfortunately, one of the side effects to my surgery was the potential non-diabetic peripheral neuropathy which I ended up getting. ... I started doing research and I learned about ARA 290 which I purchased through Peptides Sciences ... I'm on my second shot so far so perhaps it's too soon to opine. ... So far so good! ... I have no side effects, such as headaches, itchiness on the injection site or any 
- claim_ids: c16
- hash: `2110dc5fe9f95ec5`

### s17 · reddit · ok
- title: ARA-290 peptide — any experience reports?
- url: https://www.reddit.com/r/neuropathy/comments/hreepv/ara290_peptide_any_experience_reports/
- summary: Positive user report of significant improvement in severe neuropathy after 1 month of ARA-290.
- quote: I am almost done with a month of ara 290. ... It’s not cheap. I have seen really great results. My neuropathy was very bad and it has improved significantly. I have tried almost everything and this was the most helpful by far. Whether it lasts I’ll have to see.
- claim_ids: c17
- hash: `035d26cc061d6b56`

### s18 · reddit · ok
- title: ARA-290 peptide — any experience reports?
- url: https://www.reddit.com/r/neuropathy/comments/hreepv/ara290_peptide_any_experience_reports/
- summary: Negative experience: painful tingling side effect leading to stopping ARA-290; pain subsided after discontinuation.
- quote: I began last week at .5 mg, then 1, then 2, then 3 and finally 4 mg. ... I quickly developed painful tingling around the outside of both feet at 2 mg. Those last 3 days were very painful. ... I have been off the peptide for 2 days now and the pain is mostly gone.
- claim_ids: c18
- hash: `b3034ca690ce289c`

### s19 · reddit · ok
- title: ARA-290 for Neuropathic Pain
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/vlbxty/ara290_for_neuropathic_pain/
- summary: User reports temporary pain relief from ARA-290 requiring ongoing use.
- quote: I’ve taken it it helps with pain but it’s temporary. You have to keep doing it from time to time at least and it’s expensive.
- claim_ids: c19
- hash: `6d3b5116bdf449c9`

### s20 · reddit · ok
- title: ARA-290 Disc Herniaton & Nerve Pain
- url: https://www.reddit.com/r/neuropathy/comments/1tvw5x6/ara290_disc_herniaton_nerve_pain/
- summary: User with post-disc herniation (surgical context implied) nerve pain reports no benefits or side effects after short use of ARA-290; planning longer cycle.
- quote: I’ve been dealing with pretty annoying nerve pain from a herniated disc at C6–C7 ... I’ve started ARA-290 ... UPDATE (07.06.2026) I had to take 2 days off from it as I was abroad ... I was on it for less than a week and didn't notice any benefits nor side effects.
- claim_ids: c20
- hash: `6ec12979c54a1f37`

### s21 · x · ok
- title: X post on ARA-290 for nerve pain
- url: https://x.com/RickWingfield5/status/2070195807316246840
- summary: Positive anecdotal report of ARA-290 helping nerve pain in neck and shoulders.
- quote: PEG-MGF has been incredible with healing my mid sixties muscles and ARA-290 is amazing for nerve pain in neck and shoulders.
- claim_ids: c21
- hash: `475ee96f38d1d692`

### s22 · pubmed · ok
- title: ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury
- url: https://pubmed.ncbi.nlm.nih.gov/40216181/
- summary: 2025 study showing ARA290 (and EPO) inhibits NLRP3 inflammasome in Schwann cells post-sciatic nerve crush injury in rats, promoting repair and functional recovery.
- quote: EPO and ARA290 promote repair and regeneration by inhibiting the activation of NLRP3 inflammasome after sciatic nerve injury.
- claim_ids: c22
- hash: `1f54fd3bb24ce5e4`

### s23 · medical · http_403
- title: ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury
- url: https://www.sciencedirect.com/science/article/abs/pii/S0014299925003644
- summary: Research article on rat sciatic nerve crush model (relevant to post-injury/surgical nerve damage); ARA290 reduces early inflammation via NLRP3 inhibition in Schwann cells, aiding regeneration.
- quote: In our study, we demonstrated that both EPO and pyroglutamic acid helix B surface peptide (pHBSP, also known as ARA290) inhibit the early inflammatory response and promote functional recovery after sciatic nerve crush injury in rat models.
- claim_ids: c23
- hash: `99ff6fd53f52c614`

### s24 · reddit · ok
- title: ARA-290 Quick Guide: The Erythropoietin-Derived Peptide Targeting Neuropathic Pain and Tissue Protection
- url: https://www.reddit.com/r/IonPeptideGuide/comments/1s0nyps/ara290_quick_guide_the_erythropoietinderived/
- summary: Detailed user guide post discussing ARA-290 mechanisms, clinical trial history, dosing, and nerve repair potential (anecdotal/educational context).
- quote: It has entered Phase I and Phase II human clinical trials for neuropathic pain (specifically in sarcoidosis patients), diabetic neuropathy, and critical limb ischemia
- claim_ids: c6
- hash: `bbfcbaa28a0bcc8e`

### s25 · review · ok
- title: Targeting the innate repair receptor to treat neuropathy
- url: https://journals.lww.com/painrpts/fulltext/2016/08000/targeting_the_innate_repair_receptor_to_treat.2.aspx
- summary: 2016 review discussing ARA290 (targeting innate repair receptor) in post-surgical neuropathic pain models like spared nerve injury (SNI) and sciatic nerve injury, showing long-term relief of allodynia.
- quote: After sciatic nerve injury, ARA290 produced a rapid and long-term relief of mechanical and cold allodynia in normal mice, but not in animals with a β-common receptor knockout phenotype. ... We tested ARA290 in the spared nerve injury (SNI) model in mice and rats. ... Animals were sham operated (blue) or received SNI and vehicle (grey) or SNI and 60 µg/kg ARA290 (red), both administered on days 1, 3, 6, 8, and 10 postsurgery (*P* < 0.0001 compared with vehicle).
- claim_ids: c25
- hash: `3751d7e3ba4e0e1a`

### s26 · medical · ok
- title: ARA-290 (Cibinetide): An EPO-Derived 11-Amino-Acid Peptide
- url: https://peptidefox.com/content/ara-290
- summary: Medical overview noting preclinical evidence from surgical nerve injury rat models (e.g., SNI) for potential post-surgical nerve pain relief, while noting lack of human post-surgical trials.
- quote: The reason to think it would help here is preclinical. The closest evidence is a rat study of a surgical nerve injury, where ARA-290 relieved touch and cold hypersensitivity and the effect vanished without the receptor. ... Could ARA-290 help lingering nerve pain after surgery, like after an ACL reconstruction? Possibly, if the pain is genuinely from a nerve (tingling, touch sensitivity), which is common after knee surgery. But be clear on the evidence: the reason to expect b
- claim_ids: c6
- hash: `10366db3f51fdfe5`

### s27 · medical · ok
- title: ARA 290 Peptide for Neuropathy and Neurodegeneration
- url: https://mindbodyneurology.com/ara-290-peptide-neuropathy/
- summary: 2025 article summarizing ARA-290 evidence including a new 2025 rat study on microneedle delivery for neuropathy and referencing surgical/preclinical models indirectly via broader neuropathy data.
- quote: A 2025 study using an ARA 290 microneedle patch in a diabetic peripheral neuropathy rat model showed relief of mechanical pain and improved nerve structure... Several key studies focus on ARA 290 in this group. ... A randomized, double-blind pilot trial in sarcoidosis with SFN symptoms...
- claim_ids: c6
- hash: `2b76803186000f31`

### s28 · other · ok
- title: ARA 290: A New Frontier in Pain Relief and Healing
- url: https://www.renewyouth.com/ara-290-a-new-frontier-in-pain-relief-and-healing/
- summary: 2025 clinic/blog post on ARA-290 for neuropathic pain and small fiber neuropathy from nerve damage (context includes post-surgical potential).
- quote: Neuropathic Pain: This type of pain is caused by nerve damage... Research suggests ARA 290 can reduce these painful sensations... Small Fiber Neuropathy: ... ARA 290 may help to repair these small nerve fibers...
- claim_ids: c6
- hash: `b10572af7bde1a48`

### s29 · medical · ok
- title: ARA-290 Peptide | Inflammation & Nerve Support
- url: https://www.paragonsportsmedicine.com/peptides/ara-290
- summary: Clinic medical resource on ARA-290 mechanisms and applications for neuropathic pain and nerve regeneration.
- quote: The peptide has gained significant attention in regenerative medicine and neurology due to its demonstrated efficacy in treating diabetic neuropathy, chronic neuropathic pain, and inflammatory conditions through its unique mechanism of promoting neural repair and reducing inflammation. ... Application Diabetic Neuropathy Neuropathic Pain
- claim_ids: c6
- hash: `b3c336c208b61251`

### s30 · review · ok
- title: ARA-290 (Cibinetide): An EPO-Derived 11-Amino-Acid Peptide Targeting the Innate Repair Receptor
- url: https://superpower.com/guides/ara-290
- summary: 2026 review of ARA-290 evidence for neuropathic pain and nerve regeneration in SFN and diabetes; discusses preclinical nerve injury models and lack of further trials.
- quote: Phase II RCTs in sarcoidosis patients showed a placebo-corrected increase in corneal nerve fiber area of 697 μm²/mm² at day 28, but no Phase III trials were completed before Araim Pharmaceuticals closed.
- claim_ids: c6
- hash: `d103ddd93bc04d3f`

### s31 · medical · ok
- title: Benefits of ARA290 Peptide: A Simple Guide
- url: https://preferredregen.com/blog/benefits-of-ara290-peptide-a-simple-guide
- summary: Blog post on ARA-290 for peripheral nerve damage including injury-related, referencing sarcoidosis studies.
- quote: ARA-290 has shown promise in helping with broader peripheral nerve damage recovery. For example, in a study on patients with sarcoidosis, a condition that can cause small fiber neuropathy, ARA-290 treatment significantly improved neuropathic symptoms and quality of life. This suggests its healing properties can be applied to various forms of nerve damage, including those from a sports injury.
- claim_ids: c31
- hash: `1e1fa925f5849136`

### s32 · instagram · ok
- title: Nerve pain treatment is also possible with peptides. ARA-290
- url: https://www.instagram.com/reel/DTadVV3j11t/
- summary: Instagram reel by foot/ankle surgeon recommending ARA-290 specifically for post-operative nerve pain and nerve injury.
- quote: ARA-290 is an excellent treatment for patients with nerve pain such as neuropathy, tarsal tunnel, nerve injury or post operative nerve pain.
- claim_ids: c32
- hash: `d9ae35e93336f023`

### s33 · reddit · ok
- title: Anybody try ARA-290 peptide for nerve damage?
- url: https://www.reddit.com/r/Biohackers/comments/1p2887b/anybody_try_ara290_peptide_for_nerve_damage/
- summary: Positive anecdotal report of significant nerve damage area reduction and symptom improvement from ARA-290 use post-vein ablation procedure (saphenous nerve axonal damage).
- quote: I've been using ARA-290 for saphenous nerve damage for 2 months. It's amazing. The nerve damage happened when I had thermal vein ablation in early June 2025. ... The boundaries of my nerve damage have shrunk several inches! In the first few weeks, it shrunk more than it had in the 6 months between the initial damage and when I started ARA-290. ... I am 100% certain that ARA-290 is responsible for my experience of several inches of recovery in mere weeks after the preceding 6 
- claim_ids: c46
- hash: `edc59b5e612b0403`

### s34 · reddit · ok
- title: ARA 290 14 days in, no relief.
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/zy6z6u/ara_290_14_days_in_no_relief/
- summary: Negative user experience reporting no pain relief or symptom improvement after 14 days of ARA-290 (user continued briefly but later discontinued without benefit).
- quote: 14 days into ARA 290 and zero relief. Losing my mind in pain. Home bound/bed bound for years now.
- claim_ids: c47
- hash: `660e97e02d8bf157`

### s35 · reddit · ok
- title: ARA-290, whats your experience?
- url: https://www.reddit.com/r/neuropathy/comments/1uavvbs/ara290_whats_your_experience/
- summary: User reports no effect from 4mg/day ARA-290 for 8 weeks on neuropathy (anecdotal, not advice). Another similar negative report for 60 days.
- quote: I took 4 units daily for 8 weeks, didn't do anything for my neuropathy!
- claim_ids: c48
- hash: `fb3c30cba012920e`

### s36 · reddit · ok
- title: ARA290
- url: https://www.reddit.com/r/neuropathy/comments/1mcbbkb/ara290/
- summary: User tried ARA290 but stopped due to insufficient relief and cost (anecdotal, not advice).
- quote: Expensive. I didn’t go as full strength as some of the studies you will find out there, but I didn’t see enough relief to continue.
- claim_ids: c49
- hash: `134f1c3a9be963c5`

### s37 · reddit · ok
- title: BPC157
- url: https://www.reddit.com/r/smallfiberneuropathy/comments/1plukvn/bpc157/
- summary: Mixed anecdotal outcome: limited overall effect from 2 months ARA290 but some reduction in nerve overfiring symptoms (anecdotal, not advice).
- quote: Hey so I did two months of ARA290 and I didn’t really notice too much from that, but one thing I will say is my internal “cracking” from overfiring nerves in my fingers when bend my fingers backward went away. Could be from the ARA.
- claim_ids: c50
- hash: `16a521ac4b3353e8`

### s38 · x · ok
- title: X post about back surgery and ARA-290
- url: https://x.com/RickWingfield5/status/2070209027057864822
- summary: Positive anecdotal report of ARA-290 helping post-back surgery nerve issues (anecdotal, not advice).
- quote: Back surgery 20 years ago Fused disc's and doing great with the ARA 290.
- claim_ids: c51
- hash: `b5e61f8b86ad3d8f`

### s39 · x · ok
- title: X post on running ARA-290
- url: https://x.com/itsjoshkade/status/2068423897226387940
- summary: Anecdotal dosing and stacking advice for nerve repair (anecdotal, not advice).
- quote: what I learned running ARA-290 (Cibinetide): 1. 1mg won't do shit. minimum 2-4mg sub-q daily. 2. don't expect results before 3-4 weeks. it builds. 3. pairs hard with BPC-157 + TB-500 for nerve repair.
- claim_ids: c52
- hash: `3dcc4f319cd7dd83`

### s40 · x · ok
- title: X post personal experience ARA-290
- url: https://x.com/CoachMattFit/status/2067657277365174754
- summary: Positive anecdotal report on ARA-290 for nerve repair and inflammation (anecdotal, not advice).
- quote: 🩹 ARA-290 Peps 🔬 My personal experience! ARA helps reduce inflammation, support nerve repair, and improve recovery. Best paired with BPC-157 for healing...
- claim_ids: c53
- hash: `e7555b5e98ee710e`

## Provenance (27 model passes)
- chain valid: yes · head: `b4d8b6aa3fca67a4`

- synthesize_body · grok/grok-4.3 · 2026-06-29T14:54 · hash `2645bdb82963`
- sources · grok-4.3 · 2026-06-29T15:57 · hash `c243a2b1f25f`
- sources · grok-4.3 · 2026-06-29T18:01 · hash `03d3169c696c`
- sources · grok-4.3 · 2026-06-29T18:02 · hash `5336b3db4b7e`
- repair · repair · 2026-06-29T19:43 · hash `ba89cbe05a6f`
- claim · fill-slots · 2026-06-29T20:57 · hash `6d9f0c86cb56`
- claim · fill-slots · 2026-06-29T20:57 · hash `e1c628a1bdef`
- voxel_divide · owner · 2026-07-17T02:38 · hash `b4d8b6aa3fca`

## Question graph
- questions: 0 · evidence ingests: 3

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"ara-290-post-surgical-nerve","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest ara-290-post-surgical-nerve|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim ara-290-post-surgical-nerve|tier|assertion`
- **iMessage ask:** `ara-290-post-surgical-nerve|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `ara-290-post-surgical-nerve`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ara-290-post-surgical-nerve/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*